Center Laboratories, Inc. (TPEX:4123)
Taiwan · Delayed Price · Currency is TWD 30.40
+0.85 (2.88%)
Sep 8, 2026, 1:30 PM CST
Center Laboratories Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 24,047 | 31,056 | 31,591 | 30,630 | 28,132 | 30,555 | |
Market Cap Growth | -16.02% | -1.69% | 3.14% | 8.88% | -7.93% | -3.72% |
Enterprise Value | 24,542 | 34,428 | 35,174 | 33,000 | 27,670 | 31,448 |
Last Close Price | 30.40 | 37.60 | 36.98 | 36.30 | 34.58 | 37.05 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 23.92 | 3.33 | - | - | 275.22 | 16.82 |
Forward PE | - | 21.73 | 21.73 | 21.73 | 21.73 | 21.73 |
PS Ratio | 14.52 | 20.48 | 19.53 | 21.97 | 36.64 | 61.10 |
PB Ratio | 1.40 | 1.17 | 1.75 | 1.52 | 1.46 | 1.45 |
P/TBV Ratio | 1.46 | 1.21 | 1.83 | 1.62 | 1.46 | 1.61 |
P/FCF Ratio | 187.21 | - | 143.23 | - | - | - |
P/OCF Ratio | 84.92 | 1143.27 | 80.03 | - | - | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 14.81 | 22.71 | 21.74 | 23.67 | 36.04 | 62.88 |
EV/EBITDA Ratio | - | - | 91.78 | 152.78 | 87.82 | - |
EV/EBIT Ratio | - | - | 150.28 | 420.09 | 97.39 | - |
EV/FCF Ratio | 191.07 | - | 159.48 | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.24 | 0.18 | 0.36 | 0.28 | 0.18 | 0.25 |
Debt / EBITDA Ratio | 17.69 | - | 16.64 | 24.96 | 10.97 | - |
Debt / FCF Ratio | 31.93 | - | 29.61 | - | - | - |
Net Debt / Equity Ratio | 0.03 | 0.15 | 0.25 | 0.11 | 0.06 | 0.02 |
Net Debt / EBITDA Ratio | 2.22 | -20.11 | 11.69 | 10.17 | 3.56 | -2.32 |
Net Debt / FCF Ratio | 3.85 | -22.66 | 20.31 | -1.94 | -5.68 | -1.40 |
Asset Turnover | 0.07 | 0.05 | 0.06 | 0.05 | 0.03 | 0.02 |
Inventory Turnover | 3.03 | 2.70 | 3.00 | 4.33 | 3.81 | 2.30 |
Quick Ratio | 1.61 | 0.26 | 0.49 | 1.99 | 0.65 | 2.02 |
Current Ratio | 1.85 | 0.45 | 0.82 | 2.78 | 0.73 | 4.06 |
Return on Equity (ROE) | 6.00% | 41.86% | -5.77% | -5.31% | -2.85% | 10.34% |
Return on Assets (ROA) | 0.15% | -0.75% | 0.56% | 0.19% | 0.64% | -0.55% |
Return on Invested Capital (ROIC) | 0.15% | -1.10% | 1.04% | 0.37% | 1.35% | -0.94% |
Return on Capital Employed (ROCE) | 0.30% | -1.20% | 1.10% | 0.30% | 1.30% | -0.90% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 4.24% | 30.02% | -3.49% | -3.25% | 0.36% | 5.94% |
FCF Yield | 0.53% | -0.57% | 0.70% | -3.70% | -0.70% | -1.20% |
Dividend Yield | 5.52% | 4.42% | 1.93% | 3.75% | 2.38% | 4.86% |
Payout Ratio | 53.02% | 5.79% | - | - | 1235.25% | 37.82% |
Buyback Yield / Dilution | -7.67% | -10.19% | -6.91% | -2.98% | 3.27% | -3.96% |
Total Shareholder Return | -2.15% | -5.76% | -4.98% | 0.77% | 5.66% | 0.89% |